Frederick, MD -- Akonni Biosystems®, a molecular diagnostics (MDx) company focused on developing and manufacturing rapid, high multiplex solutions for infectious disease testing, today announced receipt of a $435K grant from the National Institutes of Biomedical Imaging and Bioengineering at T

read more>>

An international team of researchers comparing recently-developed methods for diagnosing tuberculosis in children in resource-poor countries has concluded that the best test for high-risk children is the microscopic-observation drug-susceptibility (MODS) techniqueMODS detects the presence of bacte

read more>>

ROCKVILLE, Md. -- Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced today the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug Re

read more>>

BRONX, NY -- For the third time in four months, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a research grant aimed at helping people infected with multidrug-Taken

read more>>

A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard

read more>>

ROCKVILLE, MD and SEOUL, KOREA -- The emergence and spread of drug-resistant mycobacterium tuberculosis (TB) threatens global TB control efforts, and there is an urgent need for new diagnostic tests that rapidly identify drug sensitivity profiles of TB strainsTo help address these concerns, Seegen

read more>>

Compounds being developed against tuberculosis also show promise against deadly tropical diseases threatening millions of people, two not-for-profits groups said on Wednesday, announcing a deal to speed up drug developmentThe Global Alliance for TB Drug Development has granted the Drugs for Neglec

read more>>

ROCKVILLE -- The Aeras Global TB Vaccine Foundation today announced that James E. Connolly has been named President and Chief Executive OfficerHe joins Aeras after a career in the pharmaceutical industry, most recently as Executive Vice President and General Manager of Wyeth Vaccines. He will tak

read more>>

The Wellcome Trust has joined forces with the US National Institute of Health (NIH) to coordinate a major new genetics study in AfricaThe five year 'Human Heredity and Health in Africa' study (or 'H3Africa') will examine genetic and environmental factors underlying the development of chronic disea

read more>>

VALENCIA, Calif. -- Today the United States (U.S.) Centers for Disease Control and Prevention (CDC) issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis (TBIn these landmark guidelines, CDC advises that Interferon Gamma

read more>>